NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 87 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 205.18 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 816 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 816 | -94.8% | 0.00% | – |
| Q4 2017 | $6,000 | 0.0% | 15,562 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | -50.0% | 15,562 | -36.1% | 0.00% | – |
| Q2 2017 | $12,000 | +140.0% | 24,351 | +200.8% | 0.00% | – |
| Q1 2017 | $5,000 | -75.0% | 8,096 | -62.1% | 0.00% | – |
| Q1 2016 | $20,000 | -93.3% | 21,358 | -83.8% | 0.00% | -100.0% |
| Q3 2015 | $300,000 | +809.1% | 131,724 | +544.3% | 0.00% | – |
| Q2 2015 | $33,000 | -57.1% | 20,444 | -57.5% | 0.00% | -100.0% |
| Q1 2015 | $77,000 | -68.6% | 48,145 | -62.9% | 0.00% | -75.0% |
| Q4 2014 | $245,000 | +81.5% | 129,776 | +27.1% | 0.00% | +100.0% |
| Q3 2014 | $135,000 | -38.1% | 102,079 | -30.8% | 0.00% | -33.3% |
| Q2 2014 | $218,000 | -31.2% | 147,441 | -14.0% | 0.00% | -40.0% |
| Q1 2014 | $317,000 | +64.2% | 171,493 | +83.7% | 0.01% | +66.7% |
| Q4 2013 | $193,000 | +188.1% | 93,358 | +274.6% | 0.00% | +50.0% |
| Q2 2013 | $67,000 | – | 24,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|